XML 123 R106.htm IDEA: XBRL DOCUMENT v2.4.0.8
Schedule Of Quarterly Financial Information (Parenthetical) (Detail) (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Schedule Of Quarterly Financial Information [Line Items]                              
Net Sales $ 822.6 $ 804.8 $ 787.6 $ 779.3 $ 809.7 [1] $ 725.2 [1] $ 696.4 [1] $ 690.6 [1] $ 731.1 $ 701.0 $ 674.9 $ 642.3 $ 3,194.3 $ 2,921.9 [1] $ 2,749.3
Deferred tax valuation charge                 13            
Deferred tax valuation charge, per share                 $ 0.09            
Impact on net sales due to change in calendar periods                 14.3            
Trade names
                             
Schedule Of Quarterly Financial Information [Line Items]                              
Impairment charges 6.5                            
L'IL CRITTERS and VITAFUSION Gummy Vitamin Dietary Supplement | Business Acquisitions
                             
Schedule Of Quarterly Financial Information [Line Items]                              
Net Sales         $ 70.0                    
[1] The fourth quarter of 2012 Net Sales includes approximately $70 associated with the acquisition of the L'IL CRITTERS and VITAFUSION gummy vitamin dietary supplement business.